10/11/2026
FDA seeks public input on ibogaine trial safety
Ibogaine trials for opioid use disorder face scrutiny over safety.
Topic archive
advanced research projects agency for health
10 stories
10/9/2026
FDA seeks public input on ibogaine trials
Gabon aims to secure benefits from rising ibogaine demand
10/8/2026
Texas ibogaine trials face funding gap as federal support looms
Federal funds may replace private investment in Texas ibogaine research
10/8/2026
FDA proposes ibogaine trial design, seeks input
FDA outlines early-stage ibogaine trial design, inviting public feedback.
10/7/2026
FDA proposes strict ibogaine trial guidelines
Public input sought on inpatient care and heart monitoring
10/6/2026
FDA seeks public input on ibogaine clinical trials
Public comments sought on trial design, dosing, and safety for ibogaine studies.
10/5/2026
FDA seeks public input on ibogaine research
Agency requests feedback on clinical trial design for ibogaine drug products.
9/17/2026
ARPA-H ibogaine workshop emphasizes precision
ARPA-H workshop explores ibogaine's potential with a focus on precision.
8/10/2026
Ibogaine trials for opioid use disorder get ARPA-H boost
ARPA-H seeks to accelerate ibogaine trials for opioid treatment
7/15/2026
HHS and VA collaborate to advance psychedelic therapy
New agreement includes ibogaine research for opioid use disorder.